Akt-mediated RALY phosphorylation functions as a molecular switch governing c-Myc stability
- 29 May 2026
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-16
Abstract
The oncoprotein c-Myc is frequently dysregulated in human cancers, yet the underlying mechanisms remain elusive. Here, we identify the RNA-binding protein RALY as a critical post-translational stabilizer of c-Myc. RALY homodimerizes and acts as a scaffold to bridge the deubiquitinating enzyme USP22 to c-Myc, thereby preventing c-Myc ubiquitination and proteasomal degradation. Under physiological growth factor stimulation, RALY is phosphorylated by Akt at S106 and T160. This phosphorylation event enables ternary complex formation with USP22 and c-Myc, promoting c-Myc stabilization and driving RALY’s oncogenic activity. Furthermore, a synthetic peptide derived from RALY, termed RAMi, disrupts the RALY–USP22–c-Myc complex, destabilizes c-Myc, and exhibits potent anti-tumor effects. Together, these findings reveal Akt-mediated RALY phosphorylation as a molecular switch governing c-Myc stability and underscore the therapeutic potential of targeting the RALY–USP22–c-Myc axis in cancer. The alternative text for this image may have been generated using AI.Keywords
Funding Information
- National Natural Science Foundation of China (32470749)
- National Natural Science Foundation of China (32270811)
- National Natural Science Foundation of China (32200614)
This publication has 57 references indexed in Scilit:
- TERRA stability is regulated by RALY and polyadenylation in a telomere-specific mannerCell Reports, 2023
- The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesisCell Reports, 2023
- RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinomaCancer Letters, 2022
- RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start siteCell Reports, 2021
- RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cellsThe International Journal of Biochemistry & Cell Biology, 2017
- Deubiquitinating enzyme USP22 positively regulates c‐Myc stability and tumorigenic activity in mammalian and breast cancer cellsJournal of Cellular Physiology, 2017
- Noncoding RNAs Regulating p53 and c-Myc Signaling2016
- MYC on the Path to CancerCell, 2012
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Neural Stem Cells Maintain Their Stemness through Protein Kinase C ζ-Mediated Inhibition of TRIM32Stem Cells, 2011